Table 5.
Univariate | Multiple | |
---|---|---|
Age (y) |
0.98 (0.95-1.02) |
1.00 (0.97-1.04) |
Lymph node ratio† |
1.06 (1.02-1.11)* |
- |
Gender |
|
|
Female |
Reference |
Reference |
Male |
1.75 (0.55-5.58) |
2.19 (0.59-8.20) |
Location of tumor |
|
|
Colon |
Reference |
- |
Rectum |
1.16 (0.40-3.30) |
- |
Depth of invasion |
|
|
T1 or T2 |
Reference |
- |
T3 |
2.23 (0.47-10.51) |
- |
T4 |
1.03 (0.19-5.63) |
- |
Stage |
|
|
I |
Reference |
- |
II |
0.83 (0.09-8.02) |
- |
III |
4.60 (0.59-36.07) |
- |
Tumor grade |
|
|
I |
Reference |
- |
II |
0.95 (0.12-7.41) |
- |
III |
0.69 (0.06-7.67) |
- |
Upstage |
|
|
N0(i+) |
9.97 (1.40-71.07)* |
8.07 (1.09-59.50)* |
N0 |
Reference |
Reference |
N+ |
9.67 (2.10-44.47)* |
7.87 (1.68-36.79)* |
HE examination |
|
|
Negative |
Reference |
- |
Positive |
5.93 (1.84-19.12)* |
- |
SLN examination |
|
|
Negative |
Reference |
- |
Positive | 1.11 (0.25-4.96) | - |
HE, hematoxylin-eosin; SLN, sentinel lymph node.
Dash denotes variables were not included in the final model.
* Indicates p < 0.05.
† Ratio values were multiplied by 100.